The Commons health committee yesterday announced terms of reference for a broad inquiry into the work of Nice, the National Institute for Health and Clinical Excellence.

The committee said it wanted to examine "why Nice's decisions are increasingly being challenged" after recent controversial recommendations that the NHS should not use certain costly cancer drugs and should restrict the use of drugs to treat Alzheimer's to those with moderate forms of the disease.